Christine Cassiano | Chief Communications Officer |
David Chang | President & Chief Executive Officer |
Rafael Amado | Executive Vice President, Research & Development & Chief Medical Officer |
Alison Moore | Chief Technical Officer |
Eric Schmidt | Chief Financial Officer |
Michael Yee | Jefferies |
Salveen Richter | Goldman Sachs |
Tyler Van Buren | Cowen |
Mark Breidenbach | Oppenheimer |
Reni Benjamin | JMP Securities |
Luca Issi | RBC |
Asthika Goonewardene | Truist Securities |
John Newman | Canaccord |
Raju Prasad | William Blair |
Dane Leone | Raymond James |
Hello and thank you for standing by, and welcome to Allogene Therapeutics Fourth Quarter and Year End 2021 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be aware that today's conference call is being recorded. I would now like to turn the call over to Christine Cassiano, Chief Communications Officer.